TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APOLLOX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

APOLLOX

ST13

US500000079412331

Class

1, 40, 42

Filing

79412331

Registration

7989083

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/05/2026

Classification

Registered

Trademark type

Combined

Nice classes

1, 40, 42

Filing date

08/28/2024

Registration date

10/21/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/21/2025

Last transaction

06/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

GB

Examiner

NOLASCO-ARIAS, KENNETH E

Law office

M70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Fujifilm Diosynth Biotechnologies UK Limited

Representatives

Allisen Pawlenty Coates IP

Technical classification

Nice Classes

Class 1Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for use in industry and science; biological preparations for use in science; biological preparations for use in cell cultures for use in industry and science; cell culture reagents for scientific and research use; media for cell culture for use in industry and science; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes

Class 40

Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services in the field of biopharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid

Class 42

Scientific research, industrial research in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals and technical product research and development services in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceutical and biological products; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid

Publications

History of USPTO decisions and trademark events.

31 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/04/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/21/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/18/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/18/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/07/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/06/2026

FIMP

FINAL DISPOSITION PROCESSED

05/06/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/21/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/29/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/02/2025

PUBO

PUBLISHED FOR OPPOSITION

09/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/31/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/16/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/16/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/16/2025

RFNT

REFUSAL PROCESSED BY IB

04/26/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/10/2025

RFRR

REFUSAL PROCESSED BY MPU

04/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/12/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/12/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/12/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/06/2025

CNRT

NON-FINAL ACTION WRITTEN

03/05/2025

DOCK

ASSIGNED TO EXAMINER

03/04/2025

MAFR

APPLICATION FILING RECEIPT MAILED

12/23/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/23/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/19/2024

Continuous trademark protection

Get notified about every new filing that threatens APOLLOX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.